Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACHC · against 1,336 other Healthcare companies
Ranked #569 of 1,337 · scores higher than 57% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 50–59, including ACHC · Click a bar to see the companies
A mix: stronger EBITDA yield, but weaker earnings yield and free cash flow yield than most Healthcare peers.
| Metric | ACHC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -41.9% | 1.5% | 6% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 9.9% | 4.2% | 80% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -4.9% | -1.0% | 38% | 20% | |
| Book yieldHigher is better · 1,306 reported | 73.5% | 37.9% | 78% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 569 | 5.24T KRW (≈$3.8B) | 57 | 60 | |
| 569 | 2.0B CNY (≈$286M) | 57 | 43 | |
| 569 | 8.24T JPY (≈$56.0B) | 57 | 75 | |
| 569 | 189.3B USD | 57 | 45 | |
| 569 | 2.8B USD | 57 | 33 | |
| 569 | 1.8B USD | 57 | 52 | |
| 569 | 2.9B USD | 57 | 50 | |
| 569 | 54.0B USD | 57 | 47 | |
| 569 | 31.3B USD | 57 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score